Grants per year
Personal profile
Research Interests
My primary interests are in developing novel therapeutic combinations for the treatment of gastrointestinal cancers. I am interested in incorporating immunotherapy and molecular testing into clinical trials.
Training Experience
| 2009 | Residency, St. Vincents Hospital, Melbourne Australia |
| 2011 | Residency, University Hospitals Case Medical Center, Cleveland OH |
| 2014 | Fellowship, University of Pittsburgh Medical Center |
| 2014 | Fellowship, Northwestern University |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Medicine, MBBS, Flinders University
… → 2005
Research interests keywords
- Cancer Biology
- Colon / Rectal Cancer
- Nanotechnology
- Pancreatic Cancer
Fingerprint
Dive into the research topics where Aparna Kalyan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Prot #CTX‐009‐002: A Phase 2/3 Randomized, Controlled Study of CTX‐009 in Combination with Paclitaxel versus Paclitaxel Alone in Adult Patients with Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers who have received One Prior Systemi
Catalyst Clinical Research, LLC, Compass Therapeutics, Inc.
7/18/23 → 7/18/26
Project: Research project
-
Prot #H3B-6527-G000-101: An Open-Label Multicenter Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Subjects With Advanced Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma
PPD Investigator Services, LLC, H3 Biomedicine Inc.
2/14/18 → 2/14/21
Project: Research project
-
Prot #NC-6004-004A: A Phase 1b/2 Dose Escalation and Expansion Trial of NC-6004 (Nanoparticle Cisplatin) plus Gemcitabine in Patients with Advanced Solid Tumors or Squamous Non-Small Cell Lung, Biliary Tract, and Bladder Cancer
PPD Investigator Services, LLC, NanoCarrier Co., Ltd.
8/29/17 → 8/29/20
Project: Research project
-
Prot #DEK-DKK1-P102: A Five Part, Phase 1, Study of DKN-01 in Combination with Paclitaxel; Part A: A Dose-Escalation Study in Patients with Relapsed or Refractory Esophageal Cancer or Gastro-esophageal Junction Tumors; Part B: An Expansion Cohort in Patie
Novella Clinical, LLC, Leap Therapeutics, Inc.
5/31/17 → 5/31/23
Project: Research project
-
Combination of pembrolizumab and pelareorep promotes anti-tumour immunity in advanced pancreatic adenocarcinoma (PDAC)
Mahalingam, D., Chen, S., Xie, P., Loghmani, H., Heineman, T., Kalyan, A., Kircher, S., Helenowski, I. B., Mi, X., Maurer, V., Coffey, M., Mulcahy, M., Benson, A. & Zhang, B., Sep 21 2023, In: British Journal of Cancer. 129, 5, p. 782-790 9 p.Research output: Contribution to journal › Article › peer-review
-
Developing a Model for Cross-Institutional Educational Collaborations: The Chicago Cardio-Oncology Consortium (CCC) Experience
Minga, I., Okwuosa, T., Akhter, N., Gans, C., Pauwaa, S., Gomez-Valencia, J., Ilias-Basha, H., Pursnani, A., Kalyan, A. & DeCara, J. M., Apr 2023, In: JACC: CardioOncology. 5, 2, p. 262-266 5 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Radioembolization for Intermediate-Stage Hepatocellular Carcinoma Maintains Liver Function and Permits Systemic Therapy at Progression
Ranganathan, S., Gabr, A., Entezari, P., Gordon, A. C., Riaz, A., Desai, K., Thornburg, B., Kulik, L., Kalyan, A., Salem, R. & Lewandowski, R. J., Jun 2023, In: Journal of Vascular and Interventional Radiology. 34, 6, p. 968-975 8 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Real World Effectiveness of Atezolizumab and Bevacizumab: What Lessons Can We Learn?
Kalyan, A. & Singal, A., Jul 1 2023, In: Journal of Clinical and Experimental Hepatology. 13, 4, p. 553-555 3 p.Research output: Contribution to journal › Editorial › peer-review
-
Immunotherapy in Biliary Tract Cancers: Where Are We?
Kalyan, A., Khosla, H. & Kim, R. D., Dec 2022, In: Current oncology reports. 24, 12, p. 1821-1828 8 p.Research output: Contribution to journal › Review article › peer-review
1 Scopus citations